EspeRare Foundation
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.esperare.org
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
Phase 2
Recruiting
- Conditions
- X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
- Interventions
- Biological: ER004
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- EspeRare Foundation
- Target Recruit Count
- 20
- Registration Number
- NCT04980638
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇩🇪Universitaetsklinikum Erlangen, Erlangen, Bayern, Germany
🇮🇹IRCCS Ca' Granda Ospedale Policlinico, Milan, Italy
Rimeporide in Patients With Duchenne Muscular Dystrophy
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2019-07-18
- Lead Sponsor
- EspeRare Foundation
- Target Recruit Count
- 20
- Registration Number
- NCT02710591
- Locations
- 🇮🇹
San Raffaele Hospital, Milano, Italy
🇫🇷I-Motion - Hôpital Armand Trousseau, Paris, Ile De France, France
🇪🇸Santa Creu i Sant Pau Hospital, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath